Clinical Trial Detail

NCT ID NCT02028455
Title A Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD19 for Relapsed/Refractory CD19+ Leukemia
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Seattle Children's Hospital
Indications

leukemia

non-Hodgkin lymphoma

Therapies

Anti-CD19CAR-CD28-CD3zeta-EGFRt T cells

Age Groups: adult child

No variant requirements are available.